BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Payne JE, Chambers R, Liknaitzky P. Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice. ACS Pharmacol Transl Sci 2021;4:416-23. [PMID: 33860171 DOI: 10.1021/acsptsci.1c00034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB. Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics. J Affect Disord 2023;326:105-10. [PMID: 36720405 DOI: 10.1016/j.jad.2023.01.073] [Reference Citation Analysis]
2 Knight BJ, Harbit RC, Smith JM. Six-Step Synthesis of (±)-Lysergic Acid. J Org Chem 2023. [PMID: 36716216 DOI: 10.1021/acs.joc.2c02564] [Reference Citation Analysis]
3 Isham A, Elf P, Jackson T. Self-transcendent experiences as promoters of ecological wellbeing? Exploration of the evidence and hypotheses to be tested. Front Psychol 2022;13. [DOI: 10.3389/fpsyg.2022.1051478] [Reference Citation Analysis]
4 Stoliker D, Egan GF, Friston KJ, Razi A, Barker E. Neural Mechanisms and Psychology of Psychedelic Ego Dissolution. Pharmacol Rev 2022;74:874-915. [DOI: 10.1124/pharmrev.121.000508] [Reference Citation Analysis]
5 Radakovic C, Radakovic R, Peryer G, Geere J. Psychedelics and mindfulness: A systematic review and meta-analysis. JPS 2022;6:137-153. [DOI: 10.1556/2054.2022.00218] [Reference Citation Analysis]
6 van Elk M, Yaden DB. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review. Neurosci Biobehav Rev 2022;140:104793. [PMID: 35878791 DOI: 10.1016/j.neubiorev.2022.104793] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kiraga MK, Kuypers KPC, Uthaug MV, Ramaekers JG, Mason NL. Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees. Front Psychiatry 2022;13:883869. [DOI: 10.3389/fpsyt.2022.883869] [Reference Citation Analysis]
8 Frymann T, Whitney S, Yaden DB, Lipson J. The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences. Front Psychol 2022;13:863247. [PMID: 35677137 DOI: 10.3389/fpsyg.2022.863247] [Reference Citation Analysis]
9 James E, Keppler J, L Robertshaw T, Sessa B. N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine. Hum Psychopharmacol 2022;37:e2835. [PMID: 35175662 DOI: 10.1002/hup.2835] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Earleywine M, Low F, Lau C, De Leo J. Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns. Journal of Humanistic Psychology. [DOI: 10.1177/00221678221085800] [Reference Citation Analysis]
11 Sekula AD, Downey L, Puspanathan P. Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy. Front Psychol 2022;13:813746. [DOI: 10.3389/fpsyg.2022.813746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kiraga M, Kuypers KPC, Uthaug MV, Ramaekers J, Mason NL. Persisting decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees.. [DOI: 10.1101/2022.03.02.22271743] [Reference Citation Analysis]
13 Simonsson O, Goldberg SB. Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States. J Psychoactive Drugs 2022;:1-8. [PMID: 35000559 DOI: 10.1080/02791072.2021.2022816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]